VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283 | -77.7% | 25,528 | -67.4% | 0.03% | -71.1% |
| Q2 2023 | $1,268 | -97.2% | 78,229 | +361.8% | 0.10% | +2325.0% |
| Q3 2022 | $46,000 | -20.7% | 16,941 | +34.1% | 0.00% | -33.3% |
| Q4 2021 | $58,000 | -57.7% | 12,633 | -44.9% | 0.01% | -53.8% |
| Q2 2021 | $137,000 | -34.4% | 22,929 | -38.3% | 0.01% | -43.5% |
| Q4 2020 | $209,000 | +127.2% | 37,152 | +191.1% | 0.02% | +109.1% |
| Q2 2020 | $92,000 | +10.8% | 12,761 | +5.7% | 0.01% | +83.3% |
| Q3 2019 | $83,000 | -50.6% | 12,071 | -40.3% | 0.01% | -40.0% |
| Q2 2019 | $168,000 | -89.7% | 20,236 | -87.6% | 0.01% | -89.1% |
| Q1 2019 | $1,628,000 | +1124.1% | 163,782 | +844.3% | 0.09% | +1214.3% |
| Q4 2018 | $133,000 | -71.8% | 17,344 | -35.9% | 0.01% | -75.9% |
| Q3 2018 | $472,000 | -11.9% | 27,073 | -52.1% | 0.03% | +20.8% |
| Q2 2018 | $536,000 | +665.7% | 56,533 | +54.5% | 0.02% | +700.0% |
| Q3 2017 | $70,000 | – | 36,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |